Company news

Share this article:
Johnson & Johnson has announced plans to acquire Omrix Biorpharmaceuticals for $438 million. Omrix is expected to operate as a stand-alone entity reporting through J&J-subsidiary Ethicon. Ethicon currently holds exclusive distribution rights for Omrix's Evithrom and Evicel, two biologic-based hemostats.
 
Roche boosted its presence in the Alzheimer's sector with a merger agreement with Memory Pharmaceuticals. Under terms of the agreement, Roche will acquire Memory in a deal worth $50 million. Montvale, NJ-based Memory develops drugs for the treatment of central nervous system disorders such as Alzheimer's disease and schizophrenia. Memory and Roche already have an R&D partnership including a Phase II trial for Alzheimer's and schizophrenia and a Phase I trial for Alzheimer's. Basel, Switzerland-based Roche, which already has a major stake in the Alzheimer's pipeline, expects Memory's work to be fully integrated into Roche's R&D portfolio including the future development of its promising nicotinic alpha-7 agonists. 
Share this article:
You must be a registered member of MMM to post a comment.
close

Next Article in Business Briefs

Email Newsletters

MM&M EBOOK: PATIENT ACCESS

Patient access to pharmaceuticals is a tale of two worlds—affordability has improved for the majority, while the minority is hampered by cost, distribution and red tape. To provide marketers with a well-rounded perspective, MM&M presents this e-book chock full of key insights. Click here to access it.

More in Business Briefs

Novartis said to be stepping out of HCV

Novartis is said to have relinquished rights to an investigational hep. C treatment, signaling its exit from the therapeutic space, according to a former partner's announcement.

Monday Moves: September 15

Hires and promotions for manufacturers, regulatory and agencies

Kantar acquires Evidências, expands Brazilian presence

The company's acquisition signals the growing importance of understanding the Brazilian healthcare market and evidence-based healthcare management services.